Reaction
Superficial Vein Thrombosis reporting signals
As of the last recalculation, Superficial Vein Thrombosis appears in 795 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is IRON SUCROSE (PRR 76.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Iron Sucrose | 27 | 76.7 | 76.9 |
| Candesartan Cilexetil | 22 | 22.5 | 22.5 |
| Sodium Bicarbonate | 19 | 21.9 | 21.9 |
| Sodium Bicarbonate Injection, | 19 | 21.9 | 21.9 |
| Tranexamic Acid | 6 | 17.8 | 17.8 |
| Pemetrexed | 14 | 17.4 | 17.4 |
| Fondaparinux Sodium | 5 | 16.3 | 16.3 |
| Ifosfamide | 13 | 16.1 | 16.1 |
| Anakinra | 10 | 16.0 | 16.0 |
| Abemaciclib | 12 | 15.9 | 16.0 |
| Carfilzomib | 15 | 14.1 | 14.1 |
| Romiplostim | 8 | 14.0 | 14.0 |
| Upadacitinib | 41 | 13.8 | 13.8 |
| Baricitinib | 5 | 13.7 | 13.7 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 21 | 13.6 | 13.6 |
| Rocuronium Bromide | 5 | 11.2 | 11.2 |
| Polatuzumab Vedotin | 4 | 10.8 | 10.8 |
| Pemetrexed Disodium | 14 | 9.8 | 9.8 |
| Emicizumab | 3 | 6.4 | 6.4 |